Definitive Healthcare Corp. DH
0.95
(0.06)
(5.94%)
as of 25 Sep
- Market cap
- $146.3M
- P/E
- 0.0×
Follow DH
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
1.27 | 1.90 | 4.55 | 5.09 | 15.12 | 45.94 | 45.94 | — |
P/FCF ratio |
8.26 | 10.46 | 29.95 | 41.55 | 135.93 | 251.28 | 251.28 | — |
P/Operating CF |
112.53 | 58.93 | 243.06 | (268.36) | 595.42 | 767.12 | 767.12 | — |
P/B ratio |
0.81 | 0.79 | 0.95 | 0.76 | 1.67 | 5.50 | 5.50 | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Sales |
1.20 | 1.71 | 4.35 | 4.78 | 14.42 | 48.95 | 48.95 | — |
EV/EBITDA |
6.55 | 9.43 | 47.48 | 47.59 | 61.23 | 0.00 | 0.00 | — |
EV/Operating CF |
5.39 | 7.43 | 26.53 | 29.93 | 95.00 | 218.94 | 218.94 | — |
EV/FCF |
7.83 | 9.43 | 28.60 | 39.08 | 129.61 | 267.71 | 267.71 | — |
Quick Ratio |
1.49 | 2.13 | 2.15 | 2.78 | 3.50 | 0.65 | 0.48 | — |
Current Ratio |
1.64 | 2.30 | 2.31 | 2.94 | 3.61 | 0.72 | 0.52 | — |
Net Debt/EBITDA |
(0.36) | (1.03) | (2.25) | (3.02) | (2.99) | 9.22 | 24.47 | — |
Debt/Assets |
22.41% | 22.32% | 14.04% | 12.45% | 12.78% | 26.46% | 25.53% | 0.00% |
Debt/Equity |
0.43 | 0.40 | 0.21 | 0.18 | 0.18 | 0.39 | 0.36 | — |
Asset Turnover |
0.26 | 0.17 | 0.13 | 0.11 | 0.09 | 0.07 | 0.10 | — |
Operating CF/Net income |
(0.39) | (0.14) | (0.20) | (4.93) | (1.41) | (0.45) | 0.00 | — |
Capex/Depreciation |
(0.06) | (0.02) | (0.01) | (0.13) | (0.10) | (0.02) | (0.05) | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (28.18%) | (45.74%) | (15.10%) | (0.48%) | (1.32%) | (4.24%) | 0.00% | — | |
| (15.23%) | (28.34%) | (10.25%) | (0.34%) | (0.92%) | (2.95%) | 0.00% | — | |
ROIC |
(38.62%) | (79.31%) | (17.96%) | (1.95%) | (1.23%) | (0.61%) | (0.68%) | — |
Return on Tangible Assets |
(122.41%) | (194.14%) | (88.88%) | (2.60%) | (5.47%) | 236.51% | 0.00% | — |
Average Days of Receivables |
78.55 | 77.04 | 86.02 | 96.39 | 95.20 | 102.14 | 106.81 | — |
Research and Development Expense of Revenue |
14.40% | 14.48% | 16.88% | 15.67% | 11.17% | 9.35% | 8.71% | — |
Selling, General and Administrative Expense of Revenue |
55.18% | 52.76% | 61.01% | 63.39% | 53.72% | 41.16% | 43.50% | — |
Intangible Assets out of Total Assets |
0.60 | 0.63 | 0.77 | 0.79 | 0.76 | 0.96 | 0.98 | 0.00 |
Share Based Compensation of Revenue |
12.07% | 15.10% | 19.39% | 16.36% | 5.99% | 1.48% | 7.66% | — |
Graham Net Nets |
(0.32) | (0.23) | (0.20) | (0.20) | (0.07) | (0.08) | (0.08) | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(43.55%) | (85.64%) | (17.54%) | (0.63%) | (1.32%) | (0.81%) | (0.81%) | — |
Free Cash Flow Yield |
12.11% | 9.56% | 3.34% | 2.41% | 0.74% | 0.40% | 0.40% | — |
Revenue per Share |
2.26 | 2.16 | 2.23 | 2.20 | 1.81 | 1.22 | 0.57 | — |
Operating CF per Share |
0.50 | 0.50 | 0.37 | 0.35 | 0.27 | 0.24 | 0.14 | — |
Capex per Share |
(0.16) | (0.11) | (0.03) | (0.08) | (0.07) | (0.01) | (0.01) | — |
Free Cash Flow per Share |
0.35 | 0.39 | 0.34 | 0.27 | 0.20 | 0.22 | 0.13 | — |
Cash per Share |
1.70 | 2.49 | 2.73 | 3.28 | 4.22 | 0.26 | 0.06 | — |
Shareholders Equity per Share |
3.55 | 5.21 | 10.63 | 14.66 | 16.32 | 12.32 | 8.16 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
3.55 | 5.21 | 10.63 | 14.66 | 16.32 | 12.32 | 8.16 | — |
Free Cash Flow |
37.06 | 45.85 | 38.21 | 27.25 | 18.48 | 21.82 | 19.69 | — |
Working Capital |
100.82 | 209.01 | 223.25 | 273.14 | 321.11 | (24.88) | (33.81) | — |
Capital Expenditures |
(16.72) | (12.34) | (2.98) | (8.33) | (6.73) | (1.39) | (1.90) | — |
Net Current Asset Value |
(98.89) | (112.02) | (232.80) | (226.93) | (173.55) | (485.95) | (468.81) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.07 | 0.05 | 0.01 | 0.04 | 0.04 | 0.01 | 0.02 | — |
Net Profit Margin |
(57.52%) | (163.81%) | (80.50%) | (3.24%) | (10.74%) | (43.24%) | 0.00% | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
21.18 | 199.59 | 78.91 | 14.88 | 13.11 | 19.49 | 13.93 | — |
Cash ROIC |
5.67% | 4.77% | 2.08% | 1.50% | 0.93% | 1.19% | 1.14% | — |
Accounts Receivable Turnover |
4.59 | 4.48 | 4.26 | 4.36 | 4.35 | 4.07 | 2.95 | — |
Accounts Payable Turnover |
8.11 | 6.61 | 9.75 | 9.91 | 7.89 | 7.79 | 4.65 | — |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
22.53 | 71.78 | 44.49 | 33.81 | 41.72 | 67.83 | 42.31 | — |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
52.61 | 56.24 | 59.02 | 51.07 | 38.22 | 29.06 | 29.00 | — |
Average Payables |
7.18 | 8.28 | 4.87 | 4.30 | 5.16 | 3.91 | 4.00 | — |
Average Assets |
912.44 | 1,457.65 | 1,974.26 | 2,120.12 | 1,931.49 | 1,733.26 | 860.58 | — |
Average Common Equity |
493.09 | 903.18 | 1,340.56 | 1,490.89 | 1,347.70 | 1,205.90 | 1,206.00 | — |
Columns are period end dates